These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6181297)

  • 21. Postoperative changes in serum copper value.
    Gregoriadis GC; Apostolidis NS; Romanos AN; Paradellis TP
    Surg Gynecol Obstet; 1982 Feb; 154(2):217-21. PubMed ID: 7058481
    [No Abstract]   [Full Text] [Related]  

  • 22. S100 serum level: a tumour marker for metastatic melanoma.
    Bottoni U; Izzo P; Richetta A; Mannooranparampil TJ; Devirgiliis V; Del Giudice M; Reale MG; Frati L; Calvieri S
    Melanoma Res; 2003 Aug; 13(4):427-9. PubMed ID: 12883371
    [No Abstract]   [Full Text] [Related]  

  • 23. [The copper concentration in the blood serum of women with ovarian tumors (a preliminary report)].
    Marinov B; Tsachev K; Doganov N; Dzherov L; Atanasova B; Markova M
    Akush Ginekol (Sofiia); 2000; 39(2):36-7. PubMed ID: 10948620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Erythrocyte creatine in cord blood.
    Smith BJ; Butzner JD; Wills MR; Sabio H; Savory J
    Ann Clin Lab Sci; 1983; 13(5):439-43. PubMed ID: 6638934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Concentration of copper and zinc in blood of psoriatic patients treated topically with ointment containing 2-chloroethyl-3-chloropropyl sulfide.
    Kopff M; Wołkanin ; Strzelczyk M; Mirosław W; Borkowski A; Puczkowski S
    Pol J Pharmacol; 1998; 50(1):47-53. PubMed ID: 9662738
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreased serum tryptophan concentration predicts poor prognosis in malignant melanoma patients.
    Weinlich G; Murr C; Richardsen L; Winkler C; Fuchs D
    Dermatology; 2007; 214(1):8-14. PubMed ID: 17191041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Results of the determination of serum markers in patients with malignant melanoma.
    Lugović L; Situm M; Buljan M; Poduje S; Sebetić K
    Coll Antropol; 2007 Jan; 31 Suppl 1():7-11. PubMed ID: 17469741
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Laboratory markers of melanoma progression].
    Bánfalvi T; Edesné MB; Gergye M; Udvarhelyi N; Orosz Z; Gilde K; Kremmer T; Ottó S; Tímár J
    Magy Onkol; 2003; 47(1):89-104. PubMed ID: 12704461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Diagnostic value of copper and magnesium in hemolymphopathies and solid tumors].
    Russo N; Cipolletta L; Diadema MR; Parente A; Lonardo L
    Minerva Med; 1981 May; 72(21):1331-8. PubMed ID: 7231784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic role of circulating melanoma cells detected by reverse transcriptase-polymerase chain reaction for tyrosinase mRNA in patients with melanoma.
    Visús C; Andres R; Mayordomo JI; Martinez-Lorenzo MJ; Murillo L; Sáez-Gutiérrez B; Diestre C; Marcos I; Astier P; Godino J; Carapeto-Marquez de Prado FJ; Larrad L; Tres A
    Melanoma Res; 2007 Apr; 17(2):83-9. PubMed ID: 17496783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Tumor markers in melanoma].
    Morsches B; Prellwitz W; Benes P; Schramm P; Trumpfheller R; Korting GW
    Dermatol Monatsschr; 1984; 170(6):380-90. PubMed ID: 6205909
    [No Abstract]   [Full Text] [Related]  

  • 32. [Profiles of low-molecular proteome spectrum obtained through SELDI-TOF mass spectrometry in the sera of patients with metastatic malignant melanoma: pilot study].
    Lakomý R'; Greplová K; Pilný R; Budinská E; Valík D; Poprach A; Nemecek R; Vyzula R
    Klin Onkol; 2009; 22(5):228-32. PubMed ID: 19886361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Copper levels and the presence of free radical reaction products in the sera of patients with cancer of the larynx].
    Gierek T; Drózdz M; Pilch J; Jendryczko A; Piekarska J
    Otolaryngol Pol; 1988; 42(1-2):33-7. PubMed ID: 3217118
    [No Abstract]   [Full Text] [Related]  

  • 34. [S-100B and MIA (melanoma inhibiting activity) serum proteins: a prospective study of their value as melanoma progression markers].
    Dornier C; Dousset B; Legras B; Barbaud A; Schmutz JL
    Ann Dermatol Venereol; 2002 May; 129(5 Pt 1):739-40. PubMed ID: 12124520
    [No Abstract]   [Full Text] [Related]  

  • 35. Serum S-100 protein: a potentially useful prognostic marker in cutaneous melanoma.
    Abraha HD; Fuller LC; Du Vivier AW; Higgins EM; Sherwood RA
    Br J Dermatol; 1997 Sep; 137(3):381-5. PubMed ID: 9349333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase II study of weekly Kahalalide F in patients with advanced malignant melanoma.
    Martín-Algarra S; Espinosa E; Rubió J; López López JJ; Manzano JL; Carrión LA; Plazaola A; Tanovic A; Paz-Ares L
    Eur J Cancer; 2009 Mar; 45(5):732-5. PubMed ID: 19186051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic significance of tyrosinase mRNA detected by nested RT-PCR in patients with malignant melanoma.
    Glumac N; Snoj M; Hocevar M; Novakovic S
    Neoplasma; 2006; 53(1):9-14. PubMed ID: 16416006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metastatic melanoma.
    Wong KF
    Br J Haematol; 2006 Sep; 134(6):554. PubMed ID: 16787494
    [No Abstract]   [Full Text] [Related]  

  • 39. The use erythrocyte glutathione as a predictive marker for malignant melanoma.
    Moral A; Lafuente MJ; Lafuente A; Castel T; Balesta AM; Trias ML;
    Anticancer Res; 2000; 20(6C):4757-60. PubMed ID: 11205213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of serum 5-S-cysteinyldopa for monitoring human metastatic melanoma during immunochemotherapy.
    Wimmer I; Meyer JC; Seifert B; Dummer R; Flace A; Burg G
    Cancer Res; 1997 Nov; 57(22):5073-6. PubMed ID: 9371505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.